Mutations affecting the SWI/SNF complex are documented in 20% of human SMARCB1-deficient neoplasms, which affect patients of a wide age range, from infants to elderly patients in their ninth decades1,7,8. The gene discussed is SMARCB1; the disease is neoplasm.